Acta Neuropharmacologica ›› 2013, Vol. 3 ›› Issue (4): 58-64.

Previous Articles    

An Update on Neuroprotective Effects of Estrogen in Alzheimer's Disease

LIU Liang-jing, SHEN Li-xia   

  1. Department of Pharmacy,Hebei North University,Zhangjiakou,075000,China
  • Online:2013-08-26 Published:2014-06-27
  • Contact: 沈丽霞,女,教授,博士,硕士生导师;研究方向:神经药理学;Tel:+86-0313-4029423,E-mail:shenlixiacn@163.com
  • About author:刘靓靓,女,硕士研究生;研究方向:神经药理学;Tel:+86-0313-4029305,E-mail:1019770976ll@gmail.com
  • Supported by:

    河北省自然科学基金资助项目(No.H2012405016),河北省教育厅资助项目(No.Z2013069),河北北方学院创新人才培育基金(CXRC1325),2013年度河北北方学院校级重大项目(ZD201310)

Abstract: Alzheimer's disease is a disease caused by a variety of CNS-degenerating factors, characterized by deposition of amyloid beta and hyperphosphorylation of tau protein. Estrogen can inhibit neuronal cell apoptosis by inhibiting the activity of caspase, regulating of Bax and Bcl-2 expression and the ratio, increasing the content of cAMP in hypothalamic neurons and glial cells, promoting the rapid cAMP response element-binding protein (CREB) phosphorylation, influencing the N-methl-D-aspartate (NMDA) receptor expression in hippocampal cells. Estrogen also exerts direct protective effect on neuron cells by brain-derived neurotrophic factor and synaptophysin.

Key words: estrogen, phytoestrogen, Alzheimer's disease, neuronopathies

CLC Number: